Oz hints at impending CMS rule to force drug price transparency

The Trump administration hopes to issue a rule by the end of this year empowering regulators to “very forcefully” go after companies that don’t share information on drug costs, the CMS administrator said Tuesday.

Health insurers, nudged by Trump administration, pledge reform to prior authorization

Major insurers have agreed to six commitments that should make accessing care easier for patients while removing administrative burden on providers. But, the pledges’ voluntary nature makes compliance an open question.

Medicare go-broke date pushed up three years in latest trustees report

The clock is ticking to stabilize Medicare, as a key trust fund underpinning the insurance program’s hospital benefit is now set to be depleted in 2033 instead of 2036.

CMS slashes ACA sign-up periods, tightens eligibility in final rule

On Friday, the Trump administration finalized a rule that’s expected to cause between 725,000 and 1.8 million people to lose ACA coverage.

House GOP moderates tell leadership they won’t back Senate tax bill over Medicaid cuts

Patients overpaying for GLP-1 drugs, data shows

With Enhanced Subsidies Set To Expire, Consumers Could Face Higher Obamacare Costs